Form 4 for EW Edwards Lifesciences
Accepted 2022-03-22 00:00:00 ET · period of report 2022-03-22 · accession 0001225208-22-004988 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-03-22 | 2022-03-22 | EW | MUSSALLEM MICHAEL A | COB, CEO, Dir | S - Sale+OE | $112.36 | -32.5K | 79.3K | -29% | -$3.66M |
| D | 2022-03-22 | 2022-03-22 | EW | MUSSALLEM MICHAEL A | COB, CEO, Dir | M - OptEx | $21.76 | +45.0K | 124.3K | +57% | +$980.3K |
| DI | 2022-03-22 | 2022-03-22 | EW | MUSSALLEM MICHAEL A | COB, CEO, Dir | G - Gift | $0.00 | +12.5K | 3.38M | +0.4% | $0 |
| D | 2022-03-22 | 2022-03-22 | EW | MUSSALLEM MICHAEL A | COB, CEO, Dir | G - Gift | $0.00 | -12.5K | 102.2K | -11% | $0 |
| D | 2022-03-22 | 2022-03-22 | EW | MUSSALLEM MICHAEL A | COB, CEO, Dir | M - OptEx | $0.00 | -45.0K | 90.1K | -33% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-03-22 | S | D | 3,000 | $110.86 | 119,021.82 | D | — | — | (F3) This transaction was executed in multiple trades at prices ranging from $110.44 to $111.42. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected. |
| 2 | Common | Common Stock | 2022-03-22 | M | A | 45,050 | $21.76 | 124,321.82 | D By Living Trust | — | — | |
| 3 | Common | Common Stock | 2022-03-22 | S | D | 2,300 | $109.79 | 122,021.82 | D | — | — | (F2) This transaction was executed in multiple trades at prices ranging from $109.38 to $110.35. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected. |
| 4 | Common | Common Stock | 2022-03-22 | G | A | 12,500 | $0.00 | 3,381,517 | I | — | — | |
| 5 | Common | Common Stock | 2022-03-22 | S | D | 4,301 | $112.06 | 114,720.82 | D | — | — | (F4) This transaction was executed in multiple trades at prices ranging from $111.49 to $112.47. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected. |
| 6 | Common | Common Stock | 2022-03-22 | G | D | 12,500 | $0.00 | 102,220.82 | D | — | — | |
| 7 | Common | Common Stock | 2022-03-22 | S | D | 22,949 | $112.87 | 79,271.82 | D | — | — | (F5) This transaction was executed in multiple trades at prices ranging from $112.50 to $113.41. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected. |
| 8 | Derivative | Employee Stock Option (Right to Acquire) | 2022-03-22 | M | D | 45,050 | $0.00 | 90,100 | D | $21.76 · 2015-06-14 to 2022-05-13 | 45,050 Common Stock |